Henry Meds GLP-1 Program: Medications, Steps, and Pricing

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, our evidence-based library on GLP-1 therapy, weight-management protocols, and the genetics behind them. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Henry Meds or its parent company, and no affiliate links or compensation are involved.

Full head-to-head: PlexusDx vs Henry Meds →

If you are weighing Henry Meds's GLP-1 program, the practical questions are which medications it offers, how enrollment flows, and what each tier costs. This review walks through the program's mechanics as published, then adds the layer no telehealth intake covers. Pricing verified July 20, 2026; program details as of April 2026.

The Henry Meds GLP-1 lineup

Henry Meds sits in the telehealth-plus-compounding category, meaning a licensed provider evaluates you virtually and, if you qualify, a prescription routes to a retail or 503A compounding pharmacy. Its GLP-1 menu spans injectable compounded semaglutide, sublingual semaglutide, oral tirzepatide, injectable liraglutide, and oral phentermine. Notably, tirzepatide is offered in oral form only. See Henry Meds's official website for current details.

From intake to first shipment

Enrollment follows a familiar arc: you submit an intake with weight, medical history, and current medications; a clinician reviews it; and on approval a prescription is issued and filled. Nothing is charged until that prescription is written, the provider evaluation is free, and the subscription bundles medication, supplies, shipping, and ongoing care. Dose titration is handled through follow-up.

Pricing tier by tier

Henry publishes a per-medication subscription and advertises a low headline number that requires paying twelve months up front, so its month-to-month rate is higher. Here is the ladder as published, each figure labeled so you know which applies (verified July 20, 2026):

• Injectable compounded semaglutide (the flagship): $297/month month-to-month. Prepaid plans lower it — the 6-month plan is $1,482 ($247/month) and the 12-month plan is $2,364 ($197/month). Henry's advertised “$197/month” is that 12-month prepaid-in-full rate, not a month-to-month price.
• Oral (sublingual) semaglutide: $249/month month-to-month, with a $179/month tier.
• Oral tirzepatide: dissolving tablets only — Henry does not offer an injectable tirzepatide as of July 2026. It is sold as a 3-month supply at $1,047 ($891 paid in full); Henry publishes no month-to-month tirzepatide rate.
• Liraglutide (injectable): $179/month month-to-month.
• Phentermine (oral): $149/month.

There is no membership fee and no per-visit consultation fee. Month-to-month and 6-month plans auto-renew, and canceling a multi-month plan early can require paying out the remaining balance unless a medical reason prevents continuing. Henry's refund policy is not stated. Confirm all figures on Henry Meds's official website before committing.

Which compound does the work

Across every tier, the pharmacology comes from the molecule class: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide. The trial anchors are STEP for semaglutide (NEJM, 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in sleep apnea (NEJM, 2024). Endpoints and populations differ; individual outcomes vary.

The layer the program leaves out

Henry's intake captures history and current medications, but not the genetic architecture underneath your GLP-1 response. Variants in GLP1R, the receptor every one of these compounds targets, plus FTO, MC4R, and TCF7L2, describe the metabolic baseline a clinician is prescribing into. They are pathway-level markers, not response predictors, but they are context a telehealth prescription alone never records.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — Semaglutide Injection at $189/month, Tirzepatide Injection at $289/month, plus Semaglutide Oral and Tirzepatide Oral. Before any protocol, the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including the FTO, GLP1R, MC4R, and TCF7L2 variants that shape your baseline biology. It does not predict response to any specific medication — it is the test before you invest step.

Not affiliated: PlexusDx is independent of Henry Meds and has no commercial relationship with the companies reviewed here.

Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.

Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies reviewed. PlexusDx offers its own Weight Management Protocols, so this piece compares approaches within the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before starting any peptide protocol.

Compare the approach: see the Weight Management Protocols, or start upstream with the Precision Peptide Genetic Test.

Frequently Asked Questions

Which GLP-1 medications does Henry Meds offer?

As published July 20, 2026, Henry Meds offers injectable compounded semaglutide, sublingual semaglutide, oral tirzepatide, injectable liraglutide, and oral phentermine. Tirzepatide is available only in oral form; there is no injectable tirzepatide option. Confirm the current menu on Henry Meds's own site before enrolling.

How does the Henry Meds GLP-1 program start?

You complete a virtual intake covering weight, history, and medications, a licensed provider reviews it, and a prescription is issued if you qualify. The evaluation is free and nothing is charged until a prescription is written. Follow-up visits then support dose titration and side-effect management.

Is compounded semaglutide the same as the branded drug?

Compounded semaglutide is prepared by a 503A pharmacy for individual prescriptions and is not an FDA-approved product, unlike the branded version. The active molecule and its GLP-1 receptor mechanism are the same, but formulation, oversight, and labeling differ. Discuss the distinction with your provider.

Does the genetic test predict my GLP-1 results?

No. The Precision Peptide Genetic Test does not predict response to any compound or program. It analyzes pathway-level variants in GLP1R, FTO, MC4R, and TCF7L2 that describe your baseline GLP-1 biology, giving your clinician upstream context regardless of which service writes the prescription.

Keep exploring in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.